Immodulon Therapeutics Limited in London, EC2M 5QQ

Description

Data updated on: 01-11-2023

Immodulon Therapeutics is a firm with it's headquarters at EC2M 5QQ London at 475 Salisbury House. This business was formed in 2007 and is established under reg. no. 06223291. This business has been operating on the English market for seventeen years now and its current status is active. The company's Standard Industrial Classification Code is 86900 and their NACE code stands for Other human health activities. The most recent filed accounts documents cover the period up to 2022-12-31 and the most current annual confirmation statement was filed on 2023-04-23.

That firm owes its accomplishments and permanent development to a group of six directors, specifically Richard D., Joseph M., Selwyn H. and 3 other directors have been described below, who have been in charge of the company since 2023. In order to provide support to the directors, this particular firm has been utilizing the skills of Ilda G. as a secretary since the appointment on 2015-11-09.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2017-04-30	2018-04-30	2019-04-30	2020-04-30	2020-12-31	2021-12-31	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand	3 724 826	4 061 137	4 212 554	1 270 066	353 474	1 881 402	1 710 115
Current Assets	5 175 116	5 137 130	5 031 314	2 931 572	2 834 937	3 043 600	2 812 656
Debtors	1 450 290	1 075 993	818 760	1 661 506	2 481 463	1 162 198	1 102 541
Net Assets Liabilities	4 722 184	5 011 542	4 635 795	2 719 714	2 132 308	1 718 136	1 821 431
Other Debtors		1 075 993	818 760	1 661 506	1 888 219	584 697	1 102 541
Property Plant Equipment	6 513	4 884	3 663	2 748	2 290	1 717	1 288

Other Financial Data
Audit Fees Expenses			5 000
Accumulated Depreciation Impairment Property Plant Equipment	33 882	35 511	36 732	37 647	38 105	38 678	39 107
Administrative Expenses		973 344	1 045 143
Amounts Owed By Group Undertakings Participating Interests					593 244	577 501
Average Number Employees During Period	4	4	5	6	6	6	4
Comprehensive Income Expense		-2 865 455	-2 615 341
Cost Sales		2 855 966	2 208 208
Creditors	645 613	316 640	594 009	409 478	899 791	1 522 053	1 001 217
Depreciation Expense Property Plant Equipment		1 629	1 221
Depreciation Rate Used For Property Plant Equipment		25	25	25	25	25	25
Fixed Assets	192 681	191 052	198 490	197 620	197 162	196 589	9 992
Future Minimum Lease Payments Under Non-cancellable Operating Leases		86 000	95 000
Gross Profit Loss		-2 855 966	-2 208 208
Income Expense Recognised Directly In Equity		3 154 813	2 239 594
Increase From Depreciation Charge For Year Property Plant Equipment		1 629	1 221	915	458	573	429
Interest Payable Similar Charges Finance Costs		5
Investments	186 168	186 168	194 827	194 872	194 872	194 872	8 704
Investments Fixed Assets	186 168	186 168	194 827	194 872	194 872	194 872	8 704
Investments In Group Undertakings		186 168	194 827	194 872	194 872	194 872	8 704
Issue Equity Instruments		3 154 813	2 239 594
Net Current Assets Liabilities	4 529 503	4 820 490	4 437 305	2 522 094	1 935 146	1 521 547	1 811 439
Number Shares Issued Fully Paid		40 000	40 000	40 000	40 000	40 000	40 000
Number Shares Issued In Period- Gross			13 895
Operating Profit Loss		-3 829 310	-3 253 351
Other Creditors		32 834	257 240	30 099	415 537	386 464	457 575
Other Interest Receivable Similar Income Finance Income		4 512	11 372
Other Taxation Social Security Payable		2 491	10 671	7 760	584	20 758	34 490
Par Value Share			1	1	1	1	1
Profit Loss		-2 865 455	-2 615 341
Profit Loss On Ordinary Activities Before Tax		-3 824 803	-3 241 979
Property Plant Equipment Gross Cost		40 395	40 395	40 395	40 395	40 395	40 395
Tax Tax Credit On Profit Or Loss On Ordinary Activities		-959 348	-626 638
Total Assets Less Current Liabilities	4 722 184	5 011 542	4 635 795	2 719 714	2 132 308	1 718 136	1 821 431
Trade Creditors Trade Payables		281 315	326 098	371 619	483 670	1 114 831	509 152